Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Department of Radiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Pharmacol Res. 2023 Dec;198:106992. doi: 10.1016/j.phrs.2023.106992. Epub 2023 Nov 15.
Major pathologic remission (MPR, residual tumor <10%) is a promising clinical endpoint for prognosis analysis in patients with lung cancer receiving pre-operative PD-1 blockade therapy. Most of the current biomarkers for predicting MPR such as PD-L1 and tumor mutation burden (TMB) need to be obtained invasively. They cannot overcome the spatiotemporal heterogeneity or provide dynamic monitoring solutions. Radiomics and artificial intelligence (AI) models provide a practical tool enabling non-invasive follow-up observation of tumor structural information through high-throughput data analysis. Currently, AI-based models mainly focus on the single baseline scan or pipeline, namely sole radiomics or deep learning (DL). This work merged the delta-radiomics based on the slope of classic radiomics indexes within a time interval and the features extracted by deep networks from the subtraction between the baseline and follow-up images. The subtracted images describing the tumor changes were based on the transformation generated by registration. Stepwise optimization of components was performed by repeating experiments among various combinations of DL networks, registration methods, feature selection algorithms, and classifiers. The optimized model could predict MPR with a cross-validation AUC of 0.91 and an external validation AUC of 0.85. A core set of 27 features (eight classic radiomics, 15 delta-radiomics, one classic DL features, and three delta-DL features) was identified. The changes in delta-radiomics indexes during the treatment were fitted with mathematic models. The fitting results revealed that over half of the features were of non-linear dynamics. Therefore, non-linear modifications were made on eight features by replacing the original features with non-linear fitting parameters, and the modified model achieved an improved power. The dynamic hybrid model serves as a novel and promising tool to predict the response of lesions to PD-1 blockade, which implies the importance of introducing the non-linear dynamic effects and DL approaches to the original delta-radiomics in the future.
主要病理缓解 (MPR,残留肿瘤 <10%) 是预测接受术前 PD-1 阻断治疗的肺癌患者预后的有前途的临床终点。目前预测 MPR 的大多数生物标志物,如 PD-L1 和肿瘤突变负荷 (TMB),都需要进行侵入性获取。它们无法克服时空异质性或提供动态监测解决方案。放射组学和人工智能 (AI) 模型通过高通量数据分析提供了一种实用工具,可实现对肿瘤结构信息的非侵入性随访观察。目前,基于 AI 的模型主要集中在单一基线扫描或流水线,即单纯放射组学或深度学习 (DL)。本工作融合了基于经典放射组学指标斜率的增量放射组学,以及通过基线和随访图像相减提取的深层网络特征。描述肿瘤变化的减影图像基于通过配准生成的变换。通过在不同的 DL 网络、配准方法、特征选择算法和分类器组合之间重复实验,对组件进行逐步优化。优化后的模型对 MPR 的预测准确率为交叉验证 AUC 为 0.91,外部验证 AUC 为 0.85。确定了一组 27 个特征(8 个经典放射组学、15 个增量放射组学、1 个经典 DL 特征和 3 个增量-DL 特征)。对治疗过程中增量放射组学指标的变化进行数学模型拟合。拟合结果表明,超过一半的特征具有非线性动力学。因此,通过用非线性拟合参数替换原始特征,对 8 个特征进行非线性修正,修正后的模型提高了预测能力。动态混合模型是一种预测 PD-1 阻断治疗反应的新型、有前途的工具,这意味着在未来的增量放射组学中引入非线性动态效应和 DL 方法的重要性。